Targeting of Leukemia-Initiating Cells to Develop Curative Drug Therapies: Straightforward but Nontrivial Concept

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|11|1|56-71

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.11, Iss.1, 2011-01, pp. : 56-71

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Genetic Modification of Natural Killer Cells for Leukemia Therapies

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 6, Iss. 2, 2007-05 ,pp. : 101-108

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Targeting Based on a New Concept-Targeting Against TLR4 as an Example

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 15, Iss. 2, 2015-06 ,pp. : 83-87

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in Antidiabetic Drug Therapies Targeting the Enteroinsular Axis

By  

Current Drug Metabolism, Vol. 10, Iss. 2, 2009-02 ,pp. : 125-137

Bentham Science Publishers

Access to resources Recommend Favorite

Multifaceted Mechanisms for Cell Survival and Drug Targeting in Chronic Myelogenous Leukemia

By  

Current Cancer Drug Targets, Vol. 13, Iss. 1, 2013-01 ,pp. : 69-79

Bentham Science Publishers

Access to resources Recommend Favorite

Cancer Stem Cells: The Emerging Challenge of Drug Targeting

By  

Current Medicinal Chemistry, Vol. 16, Iss. 4, 2009-02 ,pp. : 394-416

Bentham Science Publishers

Access to resources Recommend Favorite